🔗 Share this article

This year's prestigious award in medical science was awarded for revolutionary findings that illuminate how the body's defense network attacks harmful pathogens while sparing the healthy tissues.

Three renowned researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this honor.

Their work identified unique "security guards" within the immune system that eliminate malfunctioning defense cells that could harming the body.

The findings are now paving the way for innovative treatments for immune disorders and cancer.

These winners will divide a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"Their research has been decisive for understanding how the body's defenses operates and why we do not all develop serious autoimmune diseases," stated the head of the award panel.

The trio's studies explain a fundamental mystery: How does the defense system defend us from numerous invaders while keeping our healthy cells intact?

The immune system uses immune cells that scan for signs of infection, including pathogens and bacteria it has not met before.

These cells employ sensors—known as recognition units—that are produced by chance in countless combinations.

That provides the defense network the ability to combat a broad range of invaders, but the unpredictability of the process unavoidably creates white blood cells that can target the body.

Security Guards of the Immune System

Scientists previously knew that a portion of these problematic defense cells were eliminated in the immune organ—where immune cells mature.

This year's award honors the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the system to disarm any immune cells that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "The discoveries have laid the foundation for a novel area of research and accelerated the development of new therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from fighting the growth, so research are aimed at lowering their numbers.

In self-attack disorders, trials are exploring boosting regulatory T-cells so the body is not under attack. A comparable method could also be effective in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their immune gland removed, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy mice could prevent the illness—suggesting there was a system for preventing defenders from harming the host.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a genetic factor vital for how T-regs function.

"Their groundbreaking work has uncovered how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the body's own tissues," said a prominent biological science expert.

"This work is a remarkable illustration of how basic physiological study can have far-reaching implications for human health."